Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053229 · ClinicalTrials.gov registry record · NA
Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization
A NA study of Muscular Atrophy and Massage Therapy, sponsored by Brigham Young University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06053229: Recruiting NA study of Muscular Atrophy and Massage Therapy, sponsored by Brigham Young University.
NCT06053229 is a NA study of Muscular Atrophy and Massage Therapy that is actively recruiting participants, run by Brigham Young University. The registered enrollment target is 36 participants, below the 121-participant average among 5 other Muscular Atrophy trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053229, a NA study of Muscular Atrophy and Massage Therapy, is actively recruiting participants, sponsored by Brigham Young University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aims of this study are to determine the effect of percussive massage (30 min/session, 2 sessions/day, daily) during 10 days of unilateral limb immobilization on preserving muscle, vascular, and mitochondrial function. The following hypotheses will be tested: Hypothesis 1: Percussive massage will attenuate the loss of size, strength and endurance over the immobilization period compared to the control group, as measured by MRI, maximal isometric and isokinetic force production and muscle endurance test using Biodex dynamometry. Hypothesis 2: Percussive massage will attenuate the loss of vascular function and blood flow compared to the control group as measured by passive leg movement and femoral artery blood flow. Hypothesis 3: Percussive massage will attenuate the loss of skeletal muscle mitochondrial function and decrease H2O2 production during immobilization compared to the control group, as measured by high-resolution respirometry.
Conditions Studied
Interventions
- DEVICE percussive massage
- COMBINATION_PRODUCT Leg Immobilization
Study Locations (1)
Utah
- Brigham Young University - Provo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What NCT06053229 shows while recruiting
NCT06053229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 121-participant average among 5 other Muscular Atrophy trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Muscular Atrophy appearing as the primary indexed condition, and to 2 interventions - of which percussive massage is the first listed.
NCT06053229 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06053229 about?
NCT06053229 is a clinical study titled "Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization". The primary aims of this study are to determine the effect of percussive massage (30 min/session, 2 sessions/day, daily) during 10 days of unilateral limb immobilization on preserving muscle, vascular, and mitochondrial function. The following hypotheses will be tested: Hypothesis 1: Percussive mas...
What is the current status of trial NCT06053229?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-03-01. Estimated completion is 2025-07-31.
What conditions does trial NCT06053229 study?
This clinical trial studies the following conditions: Muscular Atrophy, Massage Therapy.
What interventions are being tested in trial NCT06053229?
The interventions under investigation include: percussive massage (DEVICE), Leg Immobilization (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06053229?
This trial is sponsored by Brigham Young University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053229 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscular Atrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combined Effects of Nutritional and Exercise Countermeasures
COMPLETED · NA
-
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
ACTIVE NOT RECRUITING · Phase 3
-
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
COMPLETED · Phase 2
-
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
COMPLETED · Phase 3
-
Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI